Metastatic Ewing’s sarcoma represents a challenging form of bone and soft tissue cancer that has spread beyond its original location to distant parts of the body. This rare but aggressive disease most commonly affects children, teenagers, and young adults, requiring swift recognition and comprehensive treatment to improve outcomes.
Epidemiology
Ewing’s sarcoma is a rare cancer, with approximately 200 to 250 children and adolescents diagnosed each year in the United States. This type of cancer accounts for only 2 to 3 percent of all childhood cancers and represents the second most common malignant bone tumor in this age group. The disease ranks as 10 to 15 percent of all bone sarcomas among young people.[1][3][7]
The condition shows clear patterns in who it affects. Most people diagnosed with Ewing’s sarcoma are between 10 and 20 years old, with many diagnoses occurring around age 15. The tumors often develop during puberty when bones grow most rapidly. However, the disease can strike younger children and people in their late twenties to early thirties. Males experience this cancer slightly more often than females.[1][7][18]
Racial and ethnic patterns are striking. White individuals, both Hispanic and non-Hispanic, have the highest risk for Ewing’s sarcoma among all racial groups in the United States. The disease appears much less frequently in Asian Americans and is quite rare in people of African descent. It is extremely rare in children of African descent specifically.[3][7][21]
When we talk about metastatic Ewing’s sarcoma specifically, we mean cancer that has spread from the bone where it started to one or more distant sites in the body. About 25 percent of patients present with visible metastatic disease right from the start, meaning the cancer has already spread by the time of diagnosis. The most common place Ewing’s sarcoma spreads to is the lungs. Other sites include distant bones and bone marrow.[5][6][7]
Causes
Ewing’s sarcoma develops because of a specific change in a cell’s genetic material, but this change is not something a person inherits from their parents. The cancer occurs when a certain type of stem cell begins growing abnormally and these cells then multiply to form a tumor.[7]
Scientists have identified the root cause at the genetic level. A chromosomal translocation, which means two pieces of different chromosomes swap places, triggers the disease. The most common translocation involves chromosome 22 and chromosome 11. About 85 percent of Ewing’s sarcoma tumors show a specific swap called t(11;22)(q24;q12). This swap causes a gene called EWSR1 on chromosome 22 to join with another gene called FLI1 on chromosome 11. Together they create a new abnormal gene called EWS-FLI1.[3][10]
In the remaining 10 to 15 percent of cases, the EWSR1 gene fuses with a different gene called ERG through a translocation between chromosomes 21 and 22. Less commonly, other translocations create different fusion genes. These newly formed genes produce abnormal proteins that act like faulty switches, telling cells to multiply when they should not.[3][11]
Researchers do not yet know what triggers these genetic changes to happen in the first place. Importantly, they have ruled out exposure to substances that cause other cancers. This makes sense because Ewing’s sarcoma typically affects children and teenagers who have not lived long enough to experience prolonged exposure to cancer-causing chemicals or radiation. The genetic change develops in cells after a child is born rather than being passed down through families.[1][7]
It is crucial for parents to understand that nothing they did or did not do could have prevented their child from developing this cancer. Ewing’s sarcoma does not appear to be linked to family history or inherited genetic conditions. The disease simply results from a random genetic accident that occurs in a single cell, which then multiplies out of control.[7]
Risk Factors
A risk factor is anything that may increase a person’s chance of developing a disease. Unlike some other cancers, Ewing’s sarcoma has very few known risk factors, and none of them can be controlled or changed by lifestyle choices or preventive measures.[21]
Age stands as the strongest risk factor. The disease overwhelmingly affects adolescents and young adults, with most diagnoses occurring during the teenage years when bones undergo rapid growth spurts. Anyone can develop Ewing’s sarcoma at any age, but it remains most common between ages 10 and 20. The cancer can occasionally appear in younger children or adults in their twenties and thirties, though this happens less frequently.[1][3]
Being male slightly increases risk compared to being female, though the difference is not dramatic. White individuals, whether Hispanic or non-Hispanic, face higher risk than other racial groups. Asian Americans have lower rates of the disease, and African Americans rarely develop Ewing’s sarcoma. These racial patterns remain consistent across studies, though researchers do not fully understand why.[3][7][21]
Importantly, Ewing’s sarcoma does not link to environmental factors or lifestyle habits. There are no known dietary causes, no connection to physical activity levels, and no association with exposure to chemicals or radiation in the environment. Parents and patients should understand that the disease develops randomly and could not have been prevented through different choices or behaviors.[1]
The disease also does not run in families. Unlike some cancers where multiple family members may be affected due to inherited genetic mutations, Ewing’s sarcoma almost never shows this pattern. The genetic changes that cause the cancer happen spontaneously in individual cells after birth rather than being inherited.[7][9]
Symptoms
The symptoms of metastatic Ewing’s sarcoma can vary depending on where the cancer started and where it has spread. Many symptoms may seem non-specific at first, potentially mimicking other more common childhood ailments or sports injuries. This can sometimes lead to delays in diagnosis as both patients and healthcare providers may initially attribute symptoms to less serious causes.[7]
Pain represents the most common and often the first symptom. The affected bone or area near it may hurt on and off. This pain typically worsens at night, which can disturb sleep and differs from typical growing pains. The pain may start as mild and sporadic but tends to become more intense and constant over time. Unlike pain from an injury that improves with rest, pain from Ewing’s sarcoma persists and progressively worsens.[1][7][18]
Swelling or a visible lump often develops in the tissue around the affected bone. Parents or patients may notice a bump or mass on an arm, leg, or chest. These lumps may feel warm and soft to the touch, and the area around them might be red or inflamed. The swelling can limit the range of motion in nearby joints, making it harder to move an arm or leg normally. Some people develop a limp when the cancer affects bones in the leg or pelvis.[1][4][7]
Unexpected bone fractures can occur. When Ewing’s sarcoma weakens a bone, it may break even without significant injury or trauma. A bone breaking during normal activity that would not usually cause a fracture should prompt immediate medical evaluation.[1][4]
Systemic symptoms affect the whole body rather than just one area. These may include fever that comes and goes without an obvious cause like an infection. Patients may experience unexplained fatigue that does not improve with rest. Loss of appetite and unintentional weight loss can develop, particularly when the cancer has spread to multiple sites. These whole-body symptoms tend to appear more commonly in metastatic disease.[1][18]
When Ewing’s sarcoma occurs in the spine or pelvis, it may press on nerves. This can cause numbness, tingling, or weakness in the arms or legs. In rare cases where tumors develop in the spinal region, patients might lose control of bowel or bladder function, which requires emergency medical attention.[7]
Symptoms specifically related to metastatic disease depend on where the cancer has spread. If it reaches the lungs, the most common site of spread, patients might develop shortness of breath, chest pain, or a persistent cough. When cancer spreads to the bone marrow, it can interfere with normal blood cell production, leading to easy bruising, frequent infections, or severe fatigue.[6][7]
Prevention
There is currently no known way to prevent Ewing’s sarcoma. Because the disease results from random genetic changes that happen after birth and has no connection to environmental exposures, lifestyle factors, or inherited family traits, preventive strategies that work for some other cancers do not apply here.[21]
Unlike cancers linked to smoking, diet, sun exposure, or chemical exposures, Ewing’s sarcoma cannot be avoided through lifestyle modifications. Parents and patients should understand that nothing in their behavior, environment, or choices caused the disease or could have prevented it. This understanding can help reduce feelings of guilt or self-blame that sometimes accompany a cancer diagnosis.[1]
There are no screening tests available for Ewing’s sarcoma in people without symptoms. The disease is too rare to justify widespread screening programs, and no tests exist that can detect it before symptoms appear. This differs from more common cancers like breast or colon cancer where regular screening can catch disease early in people without symptoms.[21]
However, awareness of symptoms and prompt medical attention when concerning signs appear represents the most important action families can take. Because early diagnosis and treatment improve outcomes, parents and teenagers should not ignore persistent bone pain, unexplained swelling, or lumps. Seeking medical evaluation quickly when these symptoms arise, especially pain that worsens at night or does not resolve with typical treatments for injuries, can lead to earlier diagnosis.[1][7]
For survivors of Ewing’s sarcoma, long-term follow-up care is essential. The cancer and its treatment can cause late effects, which are health problems that appear months or years after treatment ends. Regular monitoring can detect and address these issues early. Survivors should also be aware that they may have a slightly increased risk of developing second cancers later in life, though this remains relatively uncommon.[1]
Pathophysiology
Understanding how Ewing’s sarcoma develops and spreads helps explain why it behaves so aggressively and why certain treatments work. The disease begins at the cellular level with specific molecular changes that transform normal cells into cancer cells.[3]
Ewing’s sarcoma originates from mesenchymal progenitor cells, which are early-stage cells that can develop into different types of connective tissue like bone, cartilage, or muscle. These progenitor cells normally receive carefully controlled signals telling them when to grow, divide, and mature into specialized cells. In Ewing’s sarcoma, the chromosomal translocation creates an abnormal fusion gene that produces a defective protein. This protein acts like a broken switch stuck in the “on” position.[3][11]
The EWS-FLI1 fusion protein, present in the majority of cases, functions as an aberrant transcription factor. Transcription factors normally act like conductors of an orchestra, turning genes on and off at the right times to control cell behavior. The abnormal fusion protein disrupts this careful control. It turns on genes that should remain silent and silences genes that should be active. This chaos causes cells to multiply rapidly and continuously rather than growing in an orderly, controlled manner.[3]
As these abnormal cells multiply, they form a mass or tumor. In bone, the tumor destroys normal bone tissue and weakens the bone’s structure. This explains why bones can fracture without significant trauma. The tumor also triggers inflammation in surrounding tissues, causing pain, warmth, and swelling. As the tumor grows larger, it may press on nearby nerves, blood vessels, or organs, creating additional symptoms.[1]
Ewing’s sarcoma is highly metastatic, meaning it has a strong tendency to spread to distant parts of the body. Even when imaging tests show cancer only in one location, microscopic clusters of cancer cells have usually already entered the bloodstream and traveled elsewhere in most patients. This is why doctors consider that 80 to 90 percent of patients have subclinical metastatic disease at the time of diagnosis, even if it cannot be seen on scans.[3][5]
The lungs are the most common site for metastatic spread because blood from all parts of the body passes through the lungs. Cancer cells traveling in the bloodstream get trapped in the small blood vessels of the lungs, where they can settle and grow. Distant bones and bone marrow are other common sites where Ewing’s sarcoma spreads. When cancer reaches the bone marrow, it can interfere with the production of normal blood cells, leading to anemia, increased infection risk, and bleeding problems.[5][6][7]
The aggressive biological behavior of Ewing’s sarcoma explains why treatment requires both local therapy (surgery or radiation to remove or destroy the main tumor) and systemic therapy (chemotherapy that travels throughout the body to kill cancer cells wherever they may be). Treating only the visible tumor would leave behind the microscopic disease that is almost always present, leading to cancer recurrence.[3][5]
The pattern of spread and the overall burden of metastatic disease significantly impact prognosis. Patients with isolated lung metastases generally have better outcomes than those with bone or bone marrow metastases. The number of metastatic sites and whether the primary tumor can be completely removed also affect survival chances. These factors help doctors classify patients into different risk groups and tailor treatment accordingly.[5][6]
